State Board of Administration of Florida Retirement System Acquires 1,567 Shares of Catalent Inc (CTLT)
State Board of Administration of Florida Retirement System increased its holdings in Catalent Inc (NYSE:CTLT) by 1.2% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 129,724 shares of the company’s stock after buying an additional 1,567 shares during the period. State Board of Administration of Florida Retirement System’s holdings in Catalent were worth $5,909,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also modified their holdings of the stock. Janus Henderson Group PLC raised its stake in Catalent by 4.3% in the second quarter. Janus Henderson Group PLC now owns 6,400,737 shares of the company’s stock worth $268,127,000 after buying an additional 266,183 shares in the last quarter. FMR LLC grew its holdings in Catalent by 1.5% in the second quarter. FMR LLC now owns 3,781,793 shares of the company’s stock worth $158,420,000 after purchasing an additional 54,678 shares during the last quarter. American Century Companies Inc. grew its holdings in Catalent by 6.4% in the second quarter. American Century Companies Inc. now owns 3,052,515 shares of the company’s stock worth $127,870,000 after purchasing an additional 183,880 shares during the last quarter. Earnest Partners LLC grew its holdings in Catalent by 0.3% in the second quarter. Earnest Partners LLC now owns 2,548,094 shares of the company’s stock worth $106,740,000 after purchasing an additional 7,628 shares during the last quarter. Finally, Macquarie Group Ltd. grew its holdings in Catalent by 25.2% in the second quarter. Macquarie Group Ltd. now owns 2,349,059 shares of the company’s stock worth $98,402,000 after purchasing an additional 472,228 shares during the last quarter. 90.11% of the stock is owned by institutional investors.
Several research firms have issued reports on CTLT. ValuEngine raised shares of Catalent from a “hold” rating to a “buy” rating in a report on Monday. Zacks Investment Research lowered shares of Catalent from a “hold” rating to a “sell” rating in a report on Monday. TheStreet lowered shares of Catalent from a “b-” rating to a “c+” rating in a report on Wednesday, November 7th. Royal Bank of Canada set a $44.00 price target on shares of Catalent and gave the stock a “buy” rating in a report on Wednesday, November 7th. Finally, Robert W. Baird began coverage on shares of Catalent in a report on Thursday. They issued an “outperform” rating on the stock. One research analyst has rated the stock with a sell rating, two have given a hold rating and nine have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $48.11.
Catalent (NYSE:CTLT) last announced its quarterly earnings data on Tuesday, November 6th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.04. The firm had revenue of $551.80 million for the quarter, compared to analyst estimates of $582.44 million. Catalent had a net margin of 2.65% and a return on equity of 19.13%. The business’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.21 earnings per share. Sell-side analysts anticipate that Catalent Inc will post 1.64 EPS for the current year.
In other news, insider John R. Chiminski sold 130,545 shares of the business’s stock in a transaction on Monday, October 1st. The shares were sold at an average price of $45.32, for a total transaction of $5,916,299.40. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Lance Miyamoto sold 6,525 shares of the business’s stock in a transaction on Tuesday, October 16th. The shares were sold at an average price of $42.50, for a total transaction of $277,312.50. The disclosure for this sale can be found here. Insiders have sold 184,335 shares of company stock worth $8,161,727 over the last three months. Corporate insiders own 1.40% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “State Board of Administration of Florida Retirement System Acquires 1,567 Shares of Catalent Inc (CTLT)” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2018/11/16/state-board-of-administration-of-florida-retirement-system-acquires-1567-shares-of-catalent-inc-ctlt.html.
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel Technologies, Biologics and Specialty Drug Delivery, Oral Drug Delivery, and Clinical Supply Services. The Softgel Technologies segment formulates, develops, and manufactures prescription and consumer soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations.
Featured Story: Short Selling Stocks and Day Traders
Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent Inc (NYSE:CTLT).
Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.